Allergan Buys Bonti, Releases New Data In Defense Of 'Iconic' Botox Brand

Allergan declared that no other brand is more 'iconic' than Botox, during its medical aesthetics investor event, but the company also revealed several defensive moves to protect the neurotoxin's status, including the acquisition of fast-acting, short duration toxin maker Bonti.

Bottles of Botulinum Toxin or Botox were rowed in the Surgery clinic display for customer showing off. Bangkok, Thailand September 2, 2017
• Source: Shutterstock

More from Strategy

More from Business